Nidan Laboratories Healthcare Ltd vs Osel Devices Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Nidan Laboratories & Healthcare Ltd is ₹ 13 as of 29 Oct 15:30 . The P/E Ratio of Nidan Laboratories & Healthcare Ltd is 0 as of March 2025 .The P/E Ratio of OSEL Devices Ltd is 19.5 as of March 2025 . The Market Cap of Nidan Laboratories & Healthcare Ltd is ₹ 0 crore as of March 2025 .The Market Cap of OSEL Devices Ltd is ₹ 390.41 crore as of March 2025 . The Dividend Payout of Nidan Laboratories & Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of OSEL Devices Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Nidan Laboratories & Healthcare Ltd

Nidan Laboratories & Healthcare Limited was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 with the Registrar of Companies, Maharashtra.
Subsequently, the name of the Company was changed from 'Abhi Diagnostic Imagings Private Limited' to 'Nidan Laboratories And Healthcare Private Limited' and fresh Certificate of Incorporation dated March 24, 2021 was issued by the Registrar of Companies.
The status of the Company was converted into a Public Limited Company and the name was changed to Nidan Laboratories & Healthcare Limited' on May 24, 2021.
At present, Company carry on the business of providing various Healthcare & Diagnostics Service Centres, such as X-Ray, Sonography, 2 D ECHO, PFT, CST, C.T. Scan, MRI, Blood Bank, Pathology Laboratories, Dialysis Unit, Intensive Care Unit, Burn & Poisoning Centre and Poly Clinic.

About OSEL Devices Ltd

Osel Devices Limited was initially incorporated on August 14, 2006 as a Private Limited Company as Innovative Infratech Soultions Private Limited'.
Subsequently, the Company's name changed to Innovative Infratech Solutions Private Limited' and a fresh Certificate of Incorporation dated November 22, 2013 was issued by the Registrar of Companies, Delhi and Haryana.
The name further changed to Osel Devices Private Limited' dated January 16, 2024 by the Registrar of Companies, at Delhi.
Further, Company converted into a Public Limited Company and the name of Company was changed to Osel Devices Limited'.
A fresh Certificate of Incorporation dated May 2, 2024 was issued by the Registrar of Companies, Central Processing Centre. Osel manufactures a comprehensive range of LED display systems and the latest hearing aids, including all major components, at ultra-modern plant.

FAQs for the comparison of Nidan Laboratories & Healthcare Ltd and OSEL Devices Ltd

Which company has a larger market capitalization, Nidan Laboratories & Healthcare Ltd or OSEL Devices Ltd?

Market cap of Nidan Laboratories & Healthcare Ltd is 18 Cr while Market cap of OSEL Devices Ltd is 597 Cr

What are the key factors driving the stock performance of Nidan Laboratories & Healthcare Ltd and OSEL Devices Ltd?

The stock performance of Nidan Laboratories & Healthcare Ltd and OSEL Devices Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nidan Laboratories & Healthcare Ltd and OSEL Devices Ltd?

As of October 31, 2026, the Nidan Laboratories & Healthcare Ltd stock price is INR ₹13.0. On the other hand, OSEL Devices Ltd stock price is INR ₹335.5.

How do dividend payouts of Nidan Laboratories & Healthcare Ltd and OSEL Devices Ltd compare?

To compare the dividend payouts of Nidan Laboratories & Healthcare Ltd and OSEL Devices Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.